Defining the cut-point between low- and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis
Ovarian low-grade and high-grade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems
PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas
Recurrent low-grade serous ovarian carcinoma is relatively chemoresistant
Previous
Previous
2010
Next
Next